Letter to FTC Re: Supplements Marketed as Opioid Withdrawal Aids
![Letter to FTC Re: Supplements Marketed as Opioid Withdrawal Aids](/sites/default/files/styles/700x530/public/media/images/resource/vasovita.png?h=79ba66ce)
CSPI writes FTC Acting Chairman Maureen K. Olhausen urging the agency to take enforcement action to protect consumers from dietary supplements that are marketed as opioid withdrawal aids.